ArticleNPJ biofilms and microbiomes2026
Pyruvate carboxylase is critical for biofilm formation in Mycobacterium tuberculosis.
Article in NPJ biofilms and microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Mycobacterium tuberculosis (Mtb) forms biofilms. Biofilm formation is critical in Mtb's virulence. The metabolic pathways governing mycobacterial biofilm formation remain largely unexplored. This study evaluated how different carbon sources influence Mtb biofilm formation. Fermentable substrates-glucose, glycerol, and pyruvate-significantly promoted thick, mature biofilm formation compared to non-fermentable alternatives. In this study, we analyzed the role of pyruvate carboxylase (Pca), an anaplerotic enzyme that converts pyruvate to oxaloacetate, in biofilm formation, as it regulates carbon metabolic flux into the tricarboxylic acid (TCA) cycle and gluconeogenesis. To this end, a transposon mutant of the pca gene was investigated for its ability to form biofilms. We observed that the pca transposon mutant is deficient in pellicle, submerged, and macrocolony biofilm formation. Confocal microscopy indicated that the pca mutant does not accumulate extracellular cellulose in the biofilms and has lower biomass. These defects could be rescued upon complementing the mutant with an episomal copy of the pca gene or adding glucose or pyruvate to the medium. These observations suggest that biofilm formation requires a regulated flow of carbon flux into gluconeogenesis and the TCA cycle to ensure the supply of precursors for EPS biosynthesis and sustained energy production to fuel EPS synthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.